Temporal transcriptome changes induced by MDV in marek's disease-resistant and -susceptible inbred chickens

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Yu, Ying ^a,c   Luo, Juan ^a   Mitra, Apratim ^a   Chang, Shuang ^b   Tian, Fei ^a   Zhang, Huanmin ^b   Yuan, Ping ^a   Zhou, Huaijun ^d   Song, Jiuzhou ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CARDIOVASCULAR DISEASE; CD8ALPHA ANTIGEN GENE; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; CTLA4 GENE; DISEASE PREDISPOSITION; DISEASE RESISTANCE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEART ARRHYTHMIA; IL8 GENE; LIFE CYCLE; MARDIVIRUS; MAREK DISEASE; NONHUMAN; PHENOTYPE; SPLEEN; USP18 GENE; ANIMAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; INBREEDING; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION STUDY;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

ANIMALS; CHICKENS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; INBREEDING; MAREK DISEASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 80053907367     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-501     Document Type: Article

References (62)

1. Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA. Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol 2005, 34(2):75-90. 10.1080/03079450500059255, 16191686.
2. Calnek BW, Witter RL. Diseases of Poultry. 1997, Ames: Iowa State University Press.
3. Davison F, Nair V. Marek's Disease: An Evolving Problem. 2004, Oxford: Elsevier Academic Press.
4. Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF, Davison TF. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci USA 2004, 101(38):13879-13884. 10.1073/pnas.0305789101, 518847, 15356338.
5. Davison A. Comments on the phylogenetics and evolution of herpesviruses and other large DNA viruses. Virus Res 2002, 82(1-2):127-132.
6. Tulman ER, Afonso CL, Lu Z, Zsak L, Rock DL, Kutish GF. The genome of a very virulent Marek's disease virus. J Virol 2000, 74(17):7980-7988. 10.1128/JVI.74.17.7980-7988.2000, 112329, 10933706.
7. Lee LF, Wu P, Sui D, Ren D, Kamil J, Kung HJ, Witter RL. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc Natl Acad Sci USA 2000, 97(11):6091-6096. 10.1073/pnas.97.11.6091, 18563, 10823954.
8. Calnek BW. Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 2001, 255:25-55. 10.1007/978-3-642-56863-3_2, 11217426.
9. Calnek BW. Marek's disease--a model for herpesvirus oncology. Crit Rev Microbiol 1986, 12(4):293-320.
10. Shek WR, Calnek BW, Schat KA, Chen CH. Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J Natl Cancer Inst 1983, 70(3):485-491.
11. Calnek BW, Schat KA, Ross LJ, Chen CL. Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection. Int J Cancer 1984, 33(3):399-406. 10.1002/ijc.2910330319, 6321365.
12. Calnek BW, Schat KA, Ross LJ, Shek WR, Chen CL. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int J Cancer 1984, 33(3):389-398. 10.1002/ijc.2910330318, 6321364.
13. Bacon LD, Hunt HD, Cheng HH. A review of the development of chicken lines to resolve genes determining resistance to diseases. Poult Sci 2000, 79(8):1082-1093.
14. Bumstead N, Sillibourne J, Rennie M, Ross N, Davison F. Quantification of Marek's disease virus in chicken lymphocytes using the polymerase chain reaction with fluorescence detection. J Virol Methods 1997, 65(1):75-81. 10.1016/S0166-0934(96)02172-6, 9128864.
15. Burgess SC, Basaran BH, Davison TF. Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet Pathol 2001, 38(2):129-142. 10.1354/vp.38-2-129, 11280369.
16. Fredericksen TL, Longenecker BM, Pazderka F, Gilmour DG, Ruth RF. A T-cell antigen system of chickens: Ly-4 and Marek's disease. Immunogenetics 1977, 5:535-552.
17. Gilmour DG, Brand A, Donnelly N, Stone HA. Bu-1 and Th-1, two loci determining surface antigens of B or T lymphocytes in the chicken. Immunogenetics 1976, 3:549-563.
18. Kaiser P, Underwood G, Davison F. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 2003, 77(1):762-768. 10.1128/JVI.77.1.762-768.2003, 140586, 12477883.
19. Yu Y, Zhang H, Tian F, Zhang W, Fang H, Song J. An integrated epigenetic and genetic analysis of DNA methyltransferase genes (DNMTs) in tumor resistant and susceptible chicken lines. PLoS One 2008, 3(7):e2672. 10.1371/journal.pone.0002672, 2481300, 18648519.
20. Vallejo RL, Bacon LD, Liu HC, Witter RL, Groenen MA, Hillel J, Cheng HH. Genetic mapping of quantitative trait loci affecting susceptibility to Marek's disease virus induced tumors in F2 intercross chickens. Genetics 1998, 148(1):349-360. 1459797, 9475745.
21. Yonash N, Bacon LD, Witter RL, Cheng HH. High resolution mapping and identification of new quantitative trait loci (QTL) affecting susceptibility to Marek's disease. Anim Genet 1999, 30(2):126-135. 10.1046/j.1365-2052.1999.00457.x, 10376303.
22. Heifetz EM, Fulton JE, O'Sullivan NP, Arthur JA, Wang J, Dekkers JC, Soller M. Mapping quantitative trait loci affecting susceptibility to Marek's disease virus in a backcross population of layer chickens. Genetics 2007, 177(4):2417-2431. 10.1534/genetics.107.080002, 2219506, 18073438.
23. Heifetz EM, Fulton JE, O'Sullivan NP, Arthur JA, Cheng H, Wang J, Soller M, Dekkers JC. Mapping QTL affecting resistance to Marek's disease in an F6 advanced intercross population of commercial layer chickens. BMC Genomics 2009, 10:20. 10.1186/1471-2164-10-20, 2651900, 19144166.
24. Sarson AJ, Parvizi P, Lepp D, Quinton M, Sharif S. Transcriptional analysis of host responses to Marek's disease virus infection in genetically resistant and susceptible chickens. Anim Genet 2008, 39(3):232-240. 10.1111/j.1365-2052.2008.01710.x, 18371127.
25. Silva RF, Coussens PM, Lee LF, Velicer LF. Current Research on Marek's Disease. 1996, American Association of Avian Pathologists, Inc.
26. Benjamini YHY. Controlling the False Discovery Rate: a Practical and Powerful Approach to Mulyiple Testing. Journal of the Royal Statistical Society B 1995, 57:289-300.
27. Liu HC, Cheng HH, Tirunagaru V, Sofer L, Burnside J. A strategy to identify positional candidate genes conferring Marek's disease resistance by integrating DNA microarrays and genetic mapping. Anim Genet 2001, 32(6):351-359. 10.1046/j.1365-2052.2001.00798.x, 11736805.
28. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004, 101(7):2173-2178. 10.1073/pnas.0308512100, 357071, 14769913.
29. Morrow T. Gene expression microarray improves prediction of breast cancer outcomes. Manag Care 2007, 16(8):51-52.
30. Tanaka H, Hata F, Nishimori H, Honmou O, Yasoshima T, Nomura H, Ohno K, Hirai I, Kamiguchi K, Isomura H, Hirohashi Y, Denno R, Sato N, Hirata K. Differential gene expression screening between parental and highly metastatic pancreatic cancer variants using a DNA microarray. J Exp Clin Cancer Res 2003, 22(2):307-313.
31. Heidari M, Sarson AJ, Huebner M, Sharif S, Kireev D, Zhou H. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling. Viral Immunol 2010, 23(3):309-319. 10.1089/vim.2009.0079, 20565294.
32. Kano R, Konnai S, Onuma M, Ohashi K. Microarray analysis of host immune responses to Marek's disease virus infection in vaccinated chickens. J Vet Med Sci 2009, 71(5):603-610. 10.1292/jvms.71.603, 19498286.
33. Morgan RW, Sofer L, Anderson AS, Bernberg EL, Cui J, Burnside J. Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus. J Virol 2001, 75(1):533-539. 10.1128/JVI.75.1.533-539.2001, 113947, 11119623.
34. Sarson AJ, Abdul-Careem MF, Zhou H, Sharif S. Transcriptional analysis of host responses to Marek's disease viral infection. Viral Immunol 2006, 19(4):747-758. 10.1089/vim.2006.19.747, 17201670.
35. Stone HA. Use of highly inbred chickens in research. In US Dept Agriculture Technical Bulletin 1975, 1514.
36. Ledbetter JA, Evans RL, Lipinski M, Cunningham-Rundles C, Good RA, Herzenberg LA. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 1981, 153(2):310-323. 10.1084/jem.153.2.310, 2186068, 6165796.
37. Salter RD, Norment AM, Chen BP, Clayberger C, Krensky AM, Littman DR, Parham P. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature 1989, 338(6213):345-347. 10.1038/338345a0, 2784196.
38. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, Clayberger C, Krensky AM, Norment AM, Littman DR, Parham P. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990, 345(6270):41-46. 10.1038/345041a0, 2109837.
39. Potter TA, Rajan TV, Dick RF, Bluestone JA. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989, 337(6202):73-75. 10.1038/337073a0, 2462676.
40. Fayen J, Huang JH, Meyerson H, Zhang D, Getty R, Greenspan N, Tykocinski M. Class I MHC alpha 3 domain can function as an independent structural unit to bind CD8 alpha. Mol Immunol 1995, 32(4):267-275. 10.1016/0161-5890(94)00149-U, 7723772.
41. Janeway CA. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 1992, 10:645-674. 10.1146/annurev.iy.10.040192.003241, 1534242.
42. Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988, 18(12):1901-1905. 10.1002/eji.1830181206, 3220103.
43. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270(5238):985-988. 10.1126/science.270.5238.985, 7481803.
44. Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993, 259(5093):368-370. 10.1126/science.7678351, 7678351.
45. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996, 271(5256):1734-1736. 10.1126/science.271.5256.1734, 8596936.
46. Abken H, Hombach A, Heuser C, Kronfeld K, Seliger B. Tuning tumor-specific T-cell activation: a matter of costimulation?. Trends Immunol 2002, 23(5):240-245. 10.1016/S1471-4906(02)02180-4, 12102744.
47. Takeda K, Kojima Y, Uno T, Hayakawa Y, Teng MW, Yoshizawa H, Yagita H, Gejyo F, Okumura K, Smyth MJ. Combination therapy of established tumors by antibodies targeting immune activating and suppressing molecules. J Immunol 2010, 184(10):5493-5501. 10.4049/jimmunol.0903033, 20400706.
48. Kumar S, Buza JJ, Burgess SC. Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity. Cancer Microenviron 2009, 2(1):23-31. 10.1007/s12307-008-0018-z, 2787926,2787926, 19308678.
49. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001, 411(6835):380-384. 10.1038/35077246, 11357146.
50. Howell SB, Dean JH, Law LW. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor. Int J Cancer 1975, 15(1):152-169. 10.1002/ijc.2910150118, 236258.
51. Ting CC, Rodrigues D. Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance. Proc Natl Acad Sci USA 1980, 77(7):4265-4269. 10.1073/pnas.77.7.4265, 349813, 6449005.
52. Baigent SJ, Davison TF. Development and composition of lymphoid lesions in the spleens of Marek's disease virus-infected chickens: association with virus spread and the pathogenesis of Marek's disease. Avian Pathology 1999, 28:287-300.
53. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 1995, 352(4):351-364.
54. Jarosinski KW, Yunis R, O'Connell PH, Markowski-Grimsrud CJ, Schat KA. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis 2002, 46(3):636-649. 10.1637/0005-2086(2002)046[0636:IOGROT]2.0.CO;2, 12243528.
55. Xing Z, Schat KA. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol 2000, 74(8):3605-3612. 10.1128/JVI.74.8.3605-3612.2000, 111870, 10729136.
56. Xing Z, Schat KA. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 2000, 100(1):70-76. 10.1046/j.1365-2567.2000.00008.x, 2326989, 10809961.
57. Yunis R, Jarosinski KW, Schat KA. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 2004, 328(1):142-150. 10.1016/j.virol.2004.07.017, 15380365.
58. Li X, Chiang HI, Zhu J, Dowd SE, Zhou H. Characterization of a newly developed chicken 44K Agilent microarray. BMC Genomics 2008, 9:60. 10.1186/1471-2164-9-60, 2262898, 18237426.
59. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003, 31(4):265-273. 10.1016/S1046-2023(03)00155-5, 14597310.
60. Yang YH, Thorne NP, Goldstein DR. Normalization for two-color cDNA microarray data. 2003, Institute of Mathematical Statistics.
61. Wilson CA, Kreychman J, Gerstein M. Assessing annotation transfer for genomics: quantifying the relations between protein sequence, structure and function through traditional and probabilistic scores. J Mol Biol 2000, 297(1):233-249. 10.1006/jmbi.2000.3550, 10704319.
62. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55(4):611-622. 10.1373/clinchem.2008.112797, 19246619.